About 2,190 results
Open links in new tab
| BioWorld
Lerna Biopharma presents first-in-class GalNAc-siRNA ... - BioWorld
Arrivent raises a $150M series A to in-license oncology assets
Vutrisiran phase III boosts Alnylam; biopharma index outperforms
Degron, Takeda bind $1.2B deal for molecular glue degraders
BioWorld MedTech: The Daily Medical Technology News Source
Generate:Biomedicines signs up Novartis to $1B+ multitarget deal
South Korea rolls out ‘Bio Economy 2.0’ to top global biologics ...
Targeting metalloproteinases can seal cerebral small vessel leaks
Stem cells eat dead cells to ensure tissue integrity | BioWorld